iCHOR Vascular Inc
One size fits all solution for peripheral clot removal (DVT & PAD) without the need for drugs or surgical intervention.
- Stage Full Product Ready
- Industry Medical Devices and Equipment
- Location Minneapolis, MN, USA
- Currency USD
- Founded November 2014
- Employees 3
- Incorporation Type C-corp
- Website ichorvascular.com
Company Summary
ICHOR Vascular has 510(k) market clearance for a 7F Percutaneous Arterial Reperfusion System (clot removal)! The 14F System is optimized for venous thrombosis and was recently 510(k) cleared on Sept 5th, 2023. ICHOR aims to be the future in treating a wide range of vascular occlusions by offering a singular product with broad utility.
Team
Advisors
-
Mike Cohn, MDUnconfirmedTroy Long MdUnconfirmedGeorge Adams, Md (UNC)Unconfirmed
-
Ken Ouriel, MDUnconfirmed
Previous Investors
-
Cleveland Clinic (GCIC)UnconfirmedOSF (Peoria, IL)Unconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.